Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL).
Eberhardt WE, Gauler TC, Lepechoux C, Stamatis G, Bildat S, Krbek T, Welter S, Grunenwald D, Fischer B, Rodrigo Hde L, Theegarten D, Le Chevalier T, Seeber S, Stuschke M, Poettgen C. Eberhardt WE, et al. Among authors: poettgen c. Lung Cancer. 2013 Oct;82(1):83-9. doi: 10.1016/j.lungcan.2013.06.007. Epub 2013 Aug 16. Lung Cancer. 2013. PMID: 23957964 Clinical Trial.
βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer.
Christoph DC, Kasper S, Gauler TC, Loesch C, Engelhard M, Theegarten D, Poettgen C, Hepp R, Peglow A, Loewendick H, Welter S, Stamatis G, Hirsch FR, Schuler M, Eberhardt WE, Wohlschlaeger J. Christoph DC, et al. Among authors: poettgen c. Br J Cancer. 2012 Aug 21;107(5):823-30. doi: 10.1038/bjc.2012.324. Epub 2012 Jul 26. Br J Cancer. 2012. PMID: 22836512 Free PMC article.
Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial.
Budach V, Stromberger C, Poettgen C, Baumann M, Budach W, Grabenbauer G, Marnitz S, Olze H, Wernecke KD, Ghadjar P. Budach V, et al. Among authors: poettgen c. Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):916-24. doi: 10.1016/j.ijrobp.2014.12.034. Epub 2015 Feb 7. Int J Radiat Oncol Biol Phys. 2015. PMID: 25670541 Clinical Trial.
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.
Guberina M, Poettgen C, Metzenmacher M, Wiesweg M, Schuler M, Aigner C, Ploenes T, Umutlu L, Gauler T, Darwiche K, Stamatis G, Theegarten D, Hautzel H, Jentzen W, Guberina N, Herrmann K, Eberhardt WEE, Stuschke M. Guberina M, et al. Among authors: poettgen c. J Nucl Med. 2021 May 20;62(12):1684-91. doi: 10.2967/jnumed.120.260646. Online ahead of print. J Nucl Med. 2021. PMID: 34016730 Free PMC article.
Long-term follow-up and health-related quality of life among cancer survivors with stage IEA orbital-type lymphoma after external photon-beam radiotherapy: Results from a longitudinal study.
Hoffmann C, Rating P, Bechrakis N, Eckstein A, Sokolenko E, Jabbarli L, Westekemper H, Mohr C, Schmeling C, Huettmann A, von Tresckow J, Göricke S, Deuschl C, Johansson P, Poettgen C, Gauler T, Guberina N, Moliavi S, Stuschke M, Guberina M. Hoffmann C, et al. Among authors: poettgen c. Hematol Oncol. 2022 Dec;40(5):922-929. doi: 10.1002/hon.3053. Epub 2022 Aug 7. Hematol Oncol. 2022. PMID: 35857866
MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy: imaging remission criteria and volumetric regression kinetics.
Hoffmann C, Mohr C, Johansson P, Eckstein A, Huettmann A, von Tresckow J, Göricke S, Deuschl C, Poettgen C, Gauler T, Guberina N, Moliavi S, Bechrakis N, Stuschke M, Guberina M. Hoffmann C, et al. Among authors: poettgen c. Sci Rep. 2023 Mar 23;13(1):4792. doi: 10.1038/s41598-023-31941-w. Sci Rep. 2023. PMID: 36959374 Free PMC article.
11 results